JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE) ›› 2021, Vol. 41 ›› Issue (9): 1207-1214.doi: 10.3969/j.issn.1674-8115.2021.09.011
• Basic research • Previous Articles
Bei-bei XUAN1(), Sai-nan GONG2, Jia-li LIU2, Quan QUAN2, Yu MENG2, Xiao-ling MU1()
Received:
2021-03-26
Online:
2021-08-24
Published:
2021-08-24
Contact:
Xiao-ling MU
E-mail:xuanbeibei0806@163.com;mxl@hospital.cqmu.edu.cn
Supported by:
CLC Number:
Bei-bei XUAN, Sai-nan GONG, Jia-li LIU, Quan QUAN, Yu MENG, Xiao-ling MU. Expression and clinical significance of DNA polymerase θ in endometrial cancer[J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(9): 1207-1214.
Add to citation manager EndNote|Ris|BibTeX
URL: https://xuebao.shsmu.edu.cn/EN/10.3969/j.issn.1674-8115.2021.09.011
Fig 3 Relationship of the POLQ expression with age, grade and prognosis of the patients in the TCGA-UCECNote:A. Comparison of POLQ expression between different ages of patients. B. Comparison of POLQ expression among different grades of patients. C. Overall survival curves of the POLQ-high expression group and -low expression group. ①P=0.003, ②P=0.000.
Group | Total/n | Expression of POLQ/n | ≥1 score/% | ≥5 score/% | |||
---|---|---|---|---|---|---|---|
- | + | ++ | +++ | ||||
EC | 127 | 9 | 54 | 38 | 26 | 92.9 | 50.4 |
Normal endometrium | 22 | 8 | 11 | 3 | 0 | 63.6 | 13.6 |
P value | ‒ | ‒ | ‒ | ‒ | ‒ | 0.000 | 0.001 |
Tab 1 Expression of POLQ in the normal endometrium and EC tissues
Group | Total/n | Expression of POLQ/n | ≥1 score/% | ≥5 score/% | |||
---|---|---|---|---|---|---|---|
- | + | ++ | +++ | ||||
EC | 127 | 9 | 54 | 38 | 26 | 92.9 | 50.4 |
Normal endometrium | 22 | 8 | 11 | 3 | 0 | 63.6 | 13.6 |
P value | ‒ | ‒ | ‒ | ‒ | ‒ | 0.000 | 0.001 |
Fig 5 Immunohistochemical staining of POLQ in the paraffin sections of normal endometrium and EC tissues (×200)Note:A/B. Negative or weakly positive in normal endometrium. C/D. Strongly positive in EC.
≥5 score/n(%) | P value | |
---|---|---|
Age/year | 0.246 | |
≥60(n=50) | 22 (44.0) | |
<60(n=77) | 42 (54.5) | |
Type | 0.742 | |
Ⅰ(n=89) | 44 (49.4) | |
Ⅱ(n=38) | 20 (52.6) | |
Stage | 0.038 | |
Ⅰ(n=83) | 35 (42.2) | |
Ⅱ(n=28) | 18 (64.3) | |
Ⅲ(n=16) | 11 (68.8) | |
Grade | 0.533 | |
1(n=23) | 14 (60.9) | |
2(n=72) | 35 (48.6) | |
3(n=32) | 15 (46.9) | |
Myometrial invasion | 0.954 | |
Superficial(n=89) | 45 (50.6) | |
Deep(n=38) | 19 (50.0) | |
Lymph node metastasis | 0.038 | |
Negative(n=121) | 49 (40.5) | |
Positive(n=6) | 5 (83.3) | |
Tumor size/cm | 0.154 | |
≥2(n=90) | 49 (54.4) | |
<2(n=37) | 15 (40.5) | |
ER① | 0.478 | |
Negative(n=19) | 11 (57.9) | |
Positive(n=104) | 51 (49.0) | |
PR① | 0.790 | |
Negative(n=27) | 13 (48.1) | |
Positive(n=96) | 49 (51.0) |
Tab 2 Expression of POLQ protein in the EC tissues of patients with different clinical characteristics
≥5 score/n(%) | P value | |
---|---|---|
Age/year | 0.246 | |
≥60(n=50) | 22 (44.0) | |
<60(n=77) | 42 (54.5) | |
Type | 0.742 | |
Ⅰ(n=89) | 44 (49.4) | |
Ⅱ(n=38) | 20 (52.6) | |
Stage | 0.038 | |
Ⅰ(n=83) | 35 (42.2) | |
Ⅱ(n=28) | 18 (64.3) | |
Ⅲ(n=16) | 11 (68.8) | |
Grade | 0.533 | |
1(n=23) | 14 (60.9) | |
2(n=72) | 35 (48.6) | |
3(n=32) | 15 (46.9) | |
Myometrial invasion | 0.954 | |
Superficial(n=89) | 45 (50.6) | |
Deep(n=38) | 19 (50.0) | |
Lymph node metastasis | 0.038 | |
Negative(n=121) | 49 (40.5) | |
Positive(n=6) | 5 (83.3) | |
Tumor size/cm | 0.154 | |
≥2(n=90) | 49 (54.4) | |
<2(n=37) | 15 (40.5) | |
ER① | 0.478 | |
Negative(n=19) | 11 (57.9) | |
Positive(n=104) | 51 (49.0) | |
PR① | 0.790 | |
Negative(n=27) | 13 (48.1) | |
Positive(n=96) | 49 (51.0) |
Fig 6 Comparison of POLQ expression in the patients with different stages and lymph node metastasis conditionsNote:A. Expression of POLQ in different stages of EC tissues. B. Expression of POLQ in the patients with and without lymph node metastasis. ①P=0.008, ②P=0.023.
Age/year | ‒ | ‒ | ‒ | |
<60 | ‒ | ‒ | ‒ | |
≥60 | ‒ | ‒ | ‒ | |
Stage | ‒ | ‒ | ‒ | |
Ⅰ‒Ⅱ | ‒ | ‒ | ‒ | |
Ⅲ | ‒ | ‒ | ‒ | |
Grade | ‒ | ‒ | ‒ | |
1‒2 | ‒ | ‒ | ‒ | |
3 | ‒ | ‒ | ‒ | |
POLQ score/score | ‒ | ‒ | ||
0‒4 | ‒ | ‒ | ||
5‒12 | ‒ | ‒ |
Tab 3 Multivariate Cox analysis of DFS and OS in the EC patients
Age/year | ‒ | ‒ | ‒ | |
<60 | ‒ | ‒ | ‒ | |
≥60 | ‒ | ‒ | ‒ | |
Stage | ‒ | ‒ | ‒ | |
Ⅰ‒Ⅱ | ‒ | ‒ | ‒ | |
Ⅲ | ‒ | ‒ | ‒ | |
Grade | ‒ | ‒ | ‒ | |
1‒2 | ‒ | ‒ | ‒ | |
3 | ‒ | ‒ | ‒ | |
POLQ score/score | ‒ | ‒ | ||
0‒4 | ‒ | ‒ | ||
5‒12 | ‒ | ‒ |
1 | Lewin SN. Revised FIGO staging system for endometrial cancer[J]. Clin Obstet Gynecol, 2011, 54(2): 215-218. |
2 | Lortet-Tieulent J, Ferlay J, Bray F, et al. International patterns and trends in endometrial cancer incidence, 1978‒2013[J]. J Natl Cancer Inst, 2018, 110(4): 354-361. |
3 | 魏丽惠. 重视子宫内膜癌的筛查[J]. 中华妇产科杂志, 2013, 48(12): 881-883. |
4 | Salvesen HB, Haldorsen IS, Trovik J. Markers for individualised therapy in endometrial carcinoma[J]. Lancet Oncol, 2012, 13(8): e353-e361. |
5 | Morice P, Leary A, Creutzberg C, et al. Endometrial cancer[J]. Lancet, 2016, 387(10023): 1094-1108. |
6 | Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015[J]. CA Cancer J Clin, 2015, 65(1): 5-29. |
7 | Ashour ME, Mosammaparast N. Mechanisms of damage tolerance and repair during DNA replication[J]. Nucleic Acids Res, 2021, 49(6): 3033-3047. |
8 | Ranjha L, Howard SM, Cejka P. Main steps in DNA double-strand break repair: an introduction to homologous recombination and related processes[J]. Chromosoma, 2018, 127(2): 187-214. |
9 | Chang HHY, Pannunzio NR, Adachi N, et al. Non-homologous DNA end joining and alternative pathways to double-strand break repair[J]. Nat Rev Mol Cell Biol, 2017, 18(8): 495-506. |
10 | Koole W, van Schendel R, Karambelas AE, et al. A polymerase theta-dependent repair pathway suppresses extensive genomic instability at endogenous G4 DNA sites[J]. Nat Commun, 2014, 5: 3216. |
11 | Yousefzadeh MJ, Wyatt DW, Takata K, et al. Mechanism of suppression of chromosomal instability by DNA polymerase POLQ[J]. PLoS Genet, 2014, 10(10): e1004654. |
12 | Kamp JA, van Schendel R, Dilweg IW, et al. BRCA1-associated structural variations are a consequence of polymerase theta-mediated end-joining[J]. Nat Commun, 2020, 11(1): 3615. |
13 | Lemée F, Bergoglio V, Fernandez-Vidal A, et al. DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability[J]. Proc Natl Acad Sci U S A, 2010, 107(30): 13390-13395. |
14 | 李学孝, 吴爱国, 胡斌, 等. DNA聚合酶θ对乳腺癌细胞株MCF-7放射敏感性的影响[J]. 中华实验外科杂志, 2012, 29(5): 801-804. |
15 | Shima N, Munroe RJ, Schimenti JC. The mouse genomic instability mutation chaos1 is an allele of Polq that exhibits genetic interaction with Atm[J]. Mol Cell Biol, 2004, 24(23): 10381-10389. |
16 | Seki M, Marini F, Wood RD. POLQ (Pol θ), a DNA polymerase and DNA-dependent ATPase in human cells[J]. Nucleic Acids Res, 2003, 31(21): 6117-6126. |
17 | Kawamura K, Bahar R, Seimiya M, et al. DNA polymerase θ is preferentially expressed in lymphoid tissues and upregulated in human cancers[J]. Int J Cancer, 2004, 109(1): 9-16. |
18 | Leoncini E, Ricciardi W, Cadoni G, et al. Adult height and head and neck cancer: a pooled analysis within the INHANCE Consortium[J]. Eur J Epidemiol, 2014, 29(1): 35-48. |
19 | Allera-Moreau C, Rouquette I, Lepage B, et al. DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early/mid-stage non-small cell lung cancer patients[J]. Oncogenesis, 2012, 1(10): e30. |
20 | Pillaire MJ, Selves J, Gordien K, et al. A 'DNA replication' signature of progression and negative outcome in colorectal cancer[J]. Oncogene, 2010, 29(6): 876-887. |
21 | Higgins GS, Harris AL, Prevo R, et al. Overexpression of POLQ confers a poor prognosis in early breast cancer patients[J]. Oncotarget, 2010, 1(3): 175-184. |
22 | Wood RD, Doublié S. DNA polymerase θ (POLQ), double-strand break repair, and cancer[J]. DNA Repair (Amst), 2016, 44: 22-32. |
23 | van Schendel R, van Heteren J, Welten R, et al. Genomic scars generated by polymerase θ reveal the versatile mechanism of alternative end-joining[J]. PLoS Genet, 2016, 12(10): e1006368. |
24 | Ahrabi S, Sarkar S, Pfister SX, et al. A role for human homologous recombination factors in suppressing microhomology-mediated end joining[J]. Nucleic Acids Res, 2016, 44(12): 5743-5757. |
25 | Goullet de Rugy T, Bashkurov M, Datti A, et al. Excess Polθ functions in response to replicative stress in homologous recombination-proficient cancer cells[J]. Biol Open, 2016, 5(10): 1485-1492. |
26 | Ceccaldi R, Liu JC, Amunugama R, et al. Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair[J]. Nature, 2015, 518(7538): 258-262. |
27 | Nik-Zainal S, Davies H, Staaf J, et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences[J]. Nature, 2016, 534(7605): 47-54. |
28 | Alexandrov LB, Nik-Zainal S, Wedge DC, et al. Signatures of mutational processes in human cancer[J]. Nature, 2013, 500(7463): 415-421. |
29 | Carvajal-Garcia J, Cho JE, Carvajal-Garcia P, et al. Mechanistic basis for microhomology identification and genome scarring by polymerase θ[J]. Proc Natl Acad Sci U S A, 2020, 117(15): 8476-8485. |
[1] | Ying XU, Yi-min CHU, Da-ming YANG, Ji LI, Hai-qin ZHANG, Hai-xia PENG. Construction of a metastasis prediction model of microsatellite instability-high colorectal cancer based on differentially expressed gene assembly [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(9): 1197-1206. |
[2] | Lei XIONG, Qian YI, Ming-fang XU, Jian CHEN. Expression and prognosis analysis of MRPL12 in lung adenocarcinoma [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(8): 1033-1040. |
[3] | Sheng CHEN, Zhi-long YAN, Ye-ming WU, Min XU, Song GU, Jing MA. Expression and clinical significance of HIF-1α/SHH signaling pathway in neuroblastoma [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(8): 1056-1061. |
[4] | Yin LIU, Tao YANG, Yu-sai XIE, Yu-zhu WANG. Screening of key genes and pathways involved in lupus nephritis based on GEO database [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 749-755. |
[5] | Sheng CHENG, Yi ZHAO, Yong-chen WANG, Ping HUANG. Meta-analysis of the effect of BRAF gene mutation on the prognosis of colorectal cancer patients with liver metastases after hepatectomy [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 786-792. |
[6] | Lu-di YANG, Gao-ming WANG, Ren-hao HU, Xiao-hua JIANG, Ran CUI. Identification of core genes in pancreatic cancer progression by bioinformatics analysis [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(5): 571-578. |
[7] | Xu-guang CHEN, Sheng-yi SHI, Lan HU, Yu CHEN, Yi-ming LU, Jing YE. Evaluative value of plasma fibrin degradation product in early prognosis of patients with hemorrhagic stroke [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(5): 612-616. |
[8] | Qi-sheng GU, Mi-li ZHANG, Can CAO, Ji-kun LI. Association of alternative splicing and tumor immune in gastric cancer based on TCGA data set [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(4): 448-458. |
[9] | Ru-juan BAO, Hui-fang CHEN, Yu DONG, You-qiong YE, Bing SU. Construction of prognostic risk score model of colorectal cancer gene signature based on transcriptome dysregulation [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(3): 285-296. |
[10] | Ren-yan WU, Xiao-lin GUO, Deng-li HONG, Lei CHEN. Identification of potential therapeutic target genes in pediatric acute leukemia of ambiguous lineage based on bioinformatics analysis [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(3): 320-327. |
[11] | Yan-ru MA, Lin-hua JI, Tian-ying TONG, Yu-qing YAN, Chao-qin SHEN, Xin-yu ZHANG, Ying-ying CAO, Jie HONG, Hao-yan CHEN. Establishment and validation of prognostic prediction model of colorectal cancer based on single-cell RNA sequencing [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(2): 159-165. |
[12] | Pei-kun HU, Jie HE, Lian-ming WU, Heng GE, Jian-rong XU, Jun PU. Effect of microvascular obstruction on left ventricle function and prognosis in patients with ST-segment elevation myocardial infarction [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(2): 173-179. |
[13] | Zhong-mao FU, Zai LUO, Ze-yin RONG, Jian-ming ZHANG, Teng-fei LI, Zhi-long YU, Chen HUANG. Study on the function and prognosis of circular RNA in colorectal cancer tissues based on high-throughput sequencing [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(2): 187-195. |
[14] | Guo-qin HU, Qin-yu LÜ, Jing ZHAO, Ming-huan ZHU, Shun-ying YU, Zheng-hui YI, Jian CHEN. Association study of non-coding variant of NOS1AP gene with schizophrenia [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(1): 29-34. |
[15] | Yan TONG, Jun-yan FANG, Hai DENG, A-hui SONG, Pu LI, Ying-li LIU. Different expression levels of exosomal miR-200a in peritoneal dialysis effluent from patients with different peritoneal transport characteristics and prediction of its biological function [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(1): 42-48. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||